| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.061 | 41.370 | 44.655 | 140.938 | 62.602 | 160.143 | 7.331 | - | - | - |
| Total Income - EUR | 30.061 | 41.350 | 45.890 | 139.154 | 62.613 | 160.143 | 7.379 | - | - | - |
| Total Expenses - EUR | 22.565 | 33.825 | 35.254 | 108.990 | 52.053 | 139.139 | 9.835 | - | - | - |
| Gross Profit/Loss - EUR | 7.496 | 7.525 | 10.635 | 30.164 | 10.560 | 21.004 | -2.456 | - | - | - |
| Net Profit/Loss - EUR | 6.594 | 6.284 | 8.460 | 25.936 | 8.671 | 19.023 | -2.676 | - | - | - |
| Employees | 1 | 1 | 1 | 0 | 0 | 1 | 0 | - | - | - |
Check the financial reports for the company - Rdc Est Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.377 | 2.616 | 0 | 11.549 | 8.712 | 5.983 | 4.179 | - | - | - |
| Current Assets | 29.290 | 37.761 | 59.700 | 71.854 | 108.811 | 95.594 | 70.604 | - | - | - |
| Inventories | 16.653 | 33.750 | 47.219 | 60.686 | 64.270 | 66.554 | 64.975 | - | - | - |
| Receivables | 12.476 | 3.047 | 12.396 | 6.589 | 22.718 | 26.558 | 481 | - | - | - |
| Cash | 162 | 964 | 85 | 4.579 | 21.823 | 2.482 | 5.147 | - | - | - |
| Shareholders Funds | 13.431 | 19.579 | 27.707 | 53.135 | 60.777 | 78.648 | 74.228 | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 20.236 | 20.798 | 31.993 | 30.269 | 56.746 | 22.929 | 554 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Rdc Est Pharm Srl